New Government Investigations Regarding Hazardous Air Pollutants Could Result In Enforcement Actions and Class Action Lawsuits
Client Alert | 3 min read | 05.02.16
Late last week, the Oregon Department of Environmental Quality (DEQ) announced an expansive and unprecedented effort to conduct inspections (including “surprise” inspections) of over 300 facilities located in the state that will concentrate initially on emissions of chromium and eight other metals (arsenic, cadmium, cobalt, lead, manganese, nickel, and selenium). This initiative followed a letter exchange with the U.S. Environmental Protection Agency (EPA) that indicated two glass manufacturing facilities located in Oregon could be subject to hazardous air pollutant (HAP) regulations.
The Oregon DEQ stated its investigation will eventually expand into a “wider variety of industrial and other air toxics” beyond the list of targeted metals. The initiative will also include enhanced air monitoring efforts and focus on “high priority” areas where industrial emissions and air toxics might affect local air quality. Therefore, while the final scope of the review is presently unknown, it has the potential to affect many different companies and industries.
The Oregon DEQ plans to require each identified facility to provide the agency with information concerning:
- Types and volumes of particular metals used
- Material Safety Data Sheets for materials used
- Operating hours and information on production
- Recent emissions testing
- Current air pollution control measures and equipment
- Results of any efforts to model ambient air concentrations of metals
The Oregon DEQ also indicates that it will determine the proximity of facilities to “residences, schools, daycare, long-term health care centers, health care facilities and correctional facilities.” DEQ plans to physically inspect 100 of the identified facilities within six weeks, and to “eventually” inspect all of the listed facilities.
The Oregon effort stems from that state’s and EPA's review of two art glass manufacturing facilities located in the Portland area, after U.S. Forest Service sampling of moss showed “bioindicators” of cadmium deposition. As a result of that work and additional state air monitoring, the current program is aimed at a broader evaluation of local air quality around industrial facilities and providing surrounding communities with greater information about proximate air emissions and potential health impacts. Significantly, the Oregon DEQ states it will endeavor to address a “regulatory gap” through new regulatory reform efforts.
Companies with facilities located in Oregon should take note of this effort. At the same time, there are strong reasons to conclude that the Oregon effort will be studied and emulated by other states and regulatory bodies.
For example, EPA has conducted a number of projects concerning community-scale air toxics monitoring (See, e.g., this project) and has held several national workshops in this area, the most recent last fall. Additionally, EPA has heightened its review of toxic air pollution from refineries, chemical plants, and other industries emitting hazardous air pollutants “that are known or suspected to cause cancer and birth defects, seriously impact the environment, and pose risks to local communities and facility employees.” Thus, the current Oregon effort will add to the growing body of information in this area, and possibly be utilized in additional rulemaking efforts.
It is also worth noting that, even prior to this Oregon initiative, the plaintiff bar initiated a series of class action lawsuits against at least one of the Portland glass manufacturers, claiming it was emitting excessive concentrations of various metals and thereby endangering human and environmental health. Accordingly, as state and potential federal investigations concerning facility air emissions proceed, it is likely the plaintiff bar will be watching closely and looking for new litigation opportunities.
Contacts
Insights
Client Alert | 5 min read | 12.12.25
Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality
On the morning of December 12, 2025, the Eleventh Circuit heard argument in United States ex rel. Zafirov v. Florida Medical Associates, LLC, et al., No. 24-13581 (11th Cir. 2025). This case concerns the constitutionality of the False Claims Act (FCA) qui tam provisions and a groundbreaking September 2024 opinion in which the United States District Court for the Middle District of Florida held that the FCA’s qui tam provisions were unconstitutional under Article II. See United States ex rel. Zafirov v. Fla. Med. Assocs., LLC, 751 F. Supp. 3d 1293 (M.D. Fla. 2024). That decision, penned by District Judge Kathryn Kimball Mizelle, was the first success story for a legal theory that has been gaining steam ever since Justices Thomas, Barrett, and Kavanaugh indicated they would be willing to consider arguments about the constitutionality of the qui tam provisions in U.S. ex rel. Polansky v. Exec. Health Res., 599 U.S. 419 (2023). In her opinion, Judge Mizelle held (1) qui tam relators are officers of the U.S. who must be appointed under the Appointments Clause; and (2) historical practice treating qui tam and similar relators as less than “officers” for constitutional purposes was not enough to save the qui tam provisions from the fundamental Article II infirmity the court identified. That ruling was appealed and, after full briefing, including by the government and a bevy of amici, the litigants stepped up to the plate this morning for oral argument.
Client Alert | 8 min read | 12.11.25
Director Squires Revamps the Workings of the U.S. Patent Office
Client Alert | 8 min read | 12.10.25
Creativity You Can Use: CJEU Clarifies Copyright for Applied Art
Client Alert | 4 min read | 12.10.25
Federal Court Strikes Down Interior Order Suspending Wind Energy Development

